Paediatric Guidelines


Guidelines available for download on this website are for information purposes only and are not intended to inform any individual clinical decisions. STSTN and its members do not accept any responsibility for outcome of clinical decisions made as a result of reading these guidelines.  All guidelines have been peer-reviewed and agreed to be published by the relevant lead consultants in the network.

The following guidelines relate to Paediatrics with sickle cell disease and thalassaemia:

Management of children with transfusion dependent thalassaemia and non-febrile acute illness guidelines *Latest version*2020

Guidelines for monitoring and annual review of children receiving regular blood transfusions *Latest version*2020

Guidelines on the management of a child with sickle cell disease and worsening anaemia *Latest version*2020

Guidelines Management Increased Jaundice in Children*Latest version*2020

Paediatrics hydroxycarbamide guidelines *Latest version*2018/19

Paediatrics management of acute chest syndrome guidelines  *Latest version*2019

Paediatric acute stroke guidelines *Latest version*2019 Thalassaemia Standards *Latest version*2018/19

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

Immunisations in the Paediatric Sickle Cell Disease Clinic at King’s College Hospital

Management of Children with Priapism and Sickle Cell Disease Joint Paediatric and Urology Clinical Guidelines

Testing for and Diagnosis of Sickle Cell Disease and Thalassaemia in Children

of Acute Abdominal Pain in Children with Sickle Cell Disease

Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia